Registry of Non-primary Angioplasty at Hospitals Without Surgery On-site (CPORT)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02137980 |
Recruitment Status :
Completed
First Posted : May 14, 2014
Last Update Posted : April 12, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Coronary Artery Disease Heart Attack Angina |
Study Type : | Observational [Patient Registry] |
Actual Enrollment : | 31390 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Target Follow-Up Duration: | 1 Week |
Official Title: | Registry of Non-primary Angioplasty at Hospitals Without Surgery On-site |
Actual Study Start Date : | April 1, 2011 |
Actual Primary Completion Date : | December 31, 2015 |
Actual Study Completion Date : | March 2016 |

- Number of participants with adverse events [ Time Frame: Thru Index or Transfer Hospital Discharge on average 24 hours ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 95 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
Patient inclusion criteria are:
Pre-catheterization
- must be undergoing diagnostic cardiac catheterization for suspected CAD
- be at least 18 years of age
- must not be pregnant (negative pregnancy test) or must not be of childbearing potential
- must be able to give informed consent. Post-catheterization
- coronary artery disease judged to be clinically and angiographically significant
- ability to perform PCI with equipment available at the local site (see below)
- procedure risk judged to be not high (see below)
Exclusion Criteria:
Patient exclusion criteria are:
Pre-catheterization
- inability to give informed consent
- ST-segment elevation myocardial infarction
- pregnancy Post-catheterization
- high likelihood of requiring a device not available at the hospitals without SOS (see below)
- no need for PCI
- need for coronary artery bypass surgery
- high procedural risk (see below)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02137980

Principal Investigator: | Thomas Aversano, MD | Johns Hopkins University |
Responsible Party: | Johns Hopkins University |
ClinicalTrials.gov Identifier: | NCT02137980 |
Other Study ID Numbers: |
NA_00046362 |
First Posted: | May 14, 2014 Key Record Dates |
Last Update Posted: | April 12, 2018 |
Last Verified: | April 2018 |
Coronary Artery Disease Myocardial Infarction Coronary Disease Myocardial Ischemia Heart Diseases |
Cardiovascular Diseases Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases |